 Alicia Byrd
Concepts (172)
Concept scores are derived automatically based on a person's publications. Keywords in the their attributed publications are matched to keywords from the National Library of Medicine's controlled vocabulary thesaurus, MeSH (Medical Subject Headings). The strength of a person's concept scores is based not only on the number of corresponding publications, but also how relevant the concepts are to the overall topics of the publications, how long ago the publications were written, whether the person was the first or senior author, and how many other people have written about the topic.Concepts cannot be directly edited. You can help ensure your concepts are accurate by making sure your attributed publications are correct and up-to-date. We recommend checking over your attributed publications list every three to four months.
Concepts are listed by decreasing relevance which is based on many factors, including how many publications the person wrote about that topic, how long ago those publications were written, and how many publications other people have written on that same topic.
| Name |
Number of Publications
|
Most Recent Publication
|
Publications by All Authors
|
Concept Score
|
Why?
|
|---|
| DNA Helicases | 32 | 2024 | 148 | 7.160 |
Why?
| | G-Quadruplexes | 15 | 2025 | 77 | 4.820 |
Why?
| | DNA, Single-Stranded | 21 | 2024 | 88 | 3.270 |
Why?
| | Saccharomyces cerevisiae Proteins | 14 | 2024 | 131 | 2.710 |
Why?
| | DNA | 15 | 2025 | 535 | 1.950 |
Why?
| | Chromatin | 4 | 2025 | 145 | 1.900 |
Why?
| | Viral Proteins | 10 | 2024 | 164 | 1.890 |
Why?
| | DNA-Binding Proteins | 10 | 2024 | 423 | 1.490 |
Why?
| | Saccharomyces cerevisiae | 13 | 2024 | 166 | 1.390 |
Why?
| | DNA Replication | 7 | 2024 | 161 | 1.220 |
Why?
| | Bacteriophage T4 | 6 | 2024 | 29 | 1.140 |
Why?
| | Nucleic Acid Conformation | 7 | 2020 | 82 | 0.810 |
Why?
| | Adenosine Triphosphate | 12 | 2024 | 211 | 0.770 |
Why?
| | RNA Helicases | 4 | 2022 | 30 | 0.720 |
Why?
| | Homologous Recombination | 1 | 2020 | 45 | 0.630 |
Why?
| | DNA, Viral | 4 | 2024 | 136 | 0.630 |
Why?
| | DNA Damage | 3 | 2021 | 309 | 0.610 |
Why?
| | Protein Binding | 12 | 2024 | 670 | 0.600 |
Why?
| | Models, Molecular | 6 | 2024 | 352 | 0.590 |
Why?
| | Gene Expression Regulation, Enzymologic | 1 | 2020 | 180 | 0.590 |
Why?
| | Promoter Regions, Genetic | 2 | 2021 | 465 | 0.590 |
Why?
| | Nuclear Proteins | 1 | 2020 | 250 | 0.570 |
Why?
| | RecQ Helicases | 2 | 2015 | 22 | 0.560 |
Why?
| | Carrier Proteins | 1 | 2020 | 315 | 0.560 |
Why?
| | Cytoplasm | 2 | 2021 | 93 | 0.520 |
Why?
| | Cytoplasmic Granules | 1 | 2016 | 17 | 0.490 |
Why?
| | Genomic Instability | 2 | 2024 | 88 | 0.480 |
Why?
| | Protein Biosynthesis | 1 | 2016 | 268 | 0.420 |
Why?
| | DEAD-box RNA Helicases | 3 | 2021 | 34 | 0.410 |
Why?
| | Crystallography, X-Ray | 6 | 2024 | 155 | 0.400 |
Why?
| | Repressor Proteins | 2 | 2021 | 149 | 0.390 |
Why?
| | RNA, Messenger | 1 | 2016 | 1133 | 0.380 |
Why?
| | Nucleic Acid Heteroduplexes | 1 | 2012 | 5 | 0.370 |
Why?
| | Bacterial Proteins | 3 | 2021 | 347 | 0.370 |
Why?
| | Oxidative Stress | 1 | 2016 | 819 | 0.350 |
Why?
| | DNA Primase | 2 | 2020 | 8 | 0.320 |
Why?
| | DNA, Fungal | 3 | 2016 | 41 | 0.320 |
Why?
| | Kinetics | 8 | 2019 | 607 | 0.310 |
Why?
| | Streptavidin | 4 | 2021 | 17 | 0.300 |
Why?
| | Humans | 16 | 2025 | 53230 | 0.290 |
Why?
| | Enzyme Inhibitors | 2 | 2021 | 371 | 0.270 |
Why?
| | Viral Nonstructural Proteins | 3 | 2022 | 60 | 0.260 |
Why?
| | Escherichia coli Proteins | 3 | 2016 | 54 | 0.260 |
Why?
| | RNA | 3 | 2022 | 173 | 0.240 |
Why?
| | Transposases | 1 | 2025 | 11 | 0.240 |
Why?
| | DNA, Mitochondrial | 2 | 2024 | 116 | 0.240 |
Why?
| | Catalysis | 2 | 2022 | 87 | 0.220 |
Why?
| | Hydrolysis | 3 | 2024 | 67 | 0.220 |
Why?
| | Sequence Analysis, DNA | 1 | 2025 | 216 | 0.220 |
Why?
| | Escherichia coli | 3 | 2016 | 183 | 0.210 |
Why?
| | High-Throughput Nucleotide Sequencing | 1 | 2025 | 180 | 0.210 |
Why?
| | Nucleic Acids | 1 | 2023 | 14 | 0.210 |
Why?
| | Cell Nucleus | 1 | 2024 | 187 | 0.200 |
Why?
| | Hepacivirus | 4 | 2022 | 105 | 0.200 |
Why?
| | Mitochondria | 2 | 2024 | 446 | 0.190 |
Why?
| | Transcription Factors | 2 | 2017 | 571 | 0.190 |
Why?
| | Oligonucleotides | 3 | 2012 | 77 | 0.180 |
Why?
| | DNA Breaks, Double-Stranded | 2 | 2020 | 76 | 0.180 |
Why?
| | Algorithms | 1 | 2025 | 667 | 0.180 |
Why?
| | Hepatitis C | 1 | 2022 | 82 | 0.180 |
Why?
| | Enzyme Assays | 1 | 2021 | 10 | 0.170 |
Why?
| | Substrate Specificity | 5 | 2021 | 197 | 0.160 |
Why?
| | Chromosome Fragile Sites | 1 | 2020 | 2 | 0.160 |
Why?
| | DNA Polymerase I | 1 | 2020 | 7 | 0.160 |
Why?
| | S Phase | 1 | 2020 | 20 | 0.160 |
Why?
| | Eukaryota | 1 | 2020 | 11 | 0.160 |
Why?
| | Cyclin-Dependent Kinase 2 | 1 | 2020 | 13 | 0.160 |
Why?
| | G1 Phase Cell Cycle Checkpoints | 1 | 2020 | 18 | 0.160 |
Why?
| | Telomere | 2 | 2023 | 38 | 0.160 |
Why?
| | Protein Structure, Tertiary | 4 | 2014 | 252 | 0.160 |
Why?
| | Genome, Human | 1 | 2020 | 121 | 0.160 |
Why?
| | HEK293 Cells | 1 | 2020 | 235 | 0.150 |
Why?
| | DNA-Directed DNA Polymerase | 1 | 2020 | 89 | 0.150 |
Why?
| | Amino Acid Sequence | 4 | 2013 | 563 | 0.150 |
Why?
| | Cell Cycle Proteins | 1 | 2020 | 170 | 0.150 |
Why?
| | Thiobarbiturates | 1 | 2018 | 22 | 0.150 |
Why?
| | Biochemical Phenomena | 1 | 2018 | 3 | 0.150 |
Why?
| | Transition Temperature | 1 | 2018 | 6 | 0.150 |
Why?
| | Phosphorylation | 1 | 2020 | 533 | 0.140 |
Why?
| | Liver Neoplasms | 1 | 2022 | 346 | 0.140 |
Why?
| | Sequence Homology, Amino Acid | 2 | 2015 | 135 | 0.130 |
Why?
| | Protein Structure, Quaternary | 1 | 2017 | 26 | 0.130 |
Why?
| | Protein Conformation | 2 | 2019 | 174 | 0.130 |
Why?
| | Binding Sites | 3 | 2024 | 373 | 0.130 |
Why?
| | Protein Transport | 2 | 2019 | 168 | 0.120 |
Why?
| | Adenosine Triphosphatases | 2 | 2016 | 92 | 0.120 |
Why?
| | Protein Interaction Maps | 1 | 2016 | 28 | 0.120 |
Why?
| | Indoles | 1 | 2018 | 280 | 0.120 |
Why?
| | Protein Interaction Mapping | 1 | 2016 | 38 | 0.120 |
Why?
| | RNA, Fungal | 1 | 2016 | 18 | 0.120 |
Why?
| | HeLa Cells | 1 | 2016 | 243 | 0.120 |
Why?
| | Bacteria | 1 | 2017 | 226 | 0.120 |
Why?
| | DNA, Complementary | 1 | 2014 | 128 | 0.110 |
Why?
| | Signal Transduction | 1 | 2021 | 1748 | 0.110 |
Why?
| | Genetic Loci | 1 | 2014 | 48 | 0.110 |
Why?
| | Models, Biological | 2 | 2019 | 737 | 0.100 |
Why?
| | Platelet Aggregation | 1 | 2013 | 77 | 0.100 |
Why?
| | Polysaccharides | 1 | 2013 | 57 | 0.100 |
Why?
| | Base Sequence | 4 | 2019 | 620 | 0.100 |
Why?
| | Mutation | 4 | 2024 | 1337 | 0.100 |
Why?
| | Proteome | 1 | 2014 | 177 | 0.090 |
Why?
| | Serotonin | 1 | 2013 | 144 | 0.090 |
Why?
| | Enzyme Stability | 1 | 2012 | 21 | 0.090 |
Why?
| | RNA Viruses | 1 | 2012 | 9 | 0.090 |
Why?
| | Amino Acid Motifs | 1 | 2012 | 59 | 0.090 |
Why?
| | DNA, Circular | 1 | 2012 | 17 | 0.090 |
Why?
| | Recombinant Proteins | 3 | 2021 | 489 | 0.090 |
Why?
| | Base Composition | 1 | 2012 | 24 | 0.090 |
Why?
| | Histones | 1 | 2014 | 318 | 0.090 |
Why?
| | Luminescent Proteins | 1 | 2011 | 48 | 0.090 |
Why?
| | Guanine | 2 | 2021 | 39 | 0.080 |
Why?
| | Recombinant Fusion Proteins | 1 | 2011 | 175 | 0.080 |
Why?
| | Mutagenesis | 2 | 2020 | 59 | 0.080 |
Why?
| | Movement | 1 | 2010 | 80 | 0.080 |
Why?
| | Structure-Activity Relationship | 2 | 2021 | 396 | 0.070 |
Why?
| | Biotinylation | 2 | 2004 | 28 | 0.070 |
Why?
| | Dimerization | 1 | 2005 | 50 | 0.060 |
Why?
| | Molecular Motor Proteins | 1 | 2004 | 8 | 0.050 |
Why?
| | DNA Repair | 2 | 2016 | 197 | 0.050 |
Why?
| | Telomere-Binding Proteins | 1 | 2023 | 9 | 0.050 |
Why?
| | Cell Membrane | 2 | 2016 | 233 | 0.050 |
Why?
| | Microscopy, Fluorescence | 2 | 2016 | 140 | 0.050 |
Why?
| | Mass Spectrometry | 2 | 2014 | 294 | 0.050 |
Why?
| | Antigens, Polyomavirus Transforming | 1 | 2002 | 8 | 0.050 |
Why?
| | Simian virus 40 | 1 | 2002 | 11 | 0.050 |
Why?
| | Molecular Sequence Data | 2 | 2014 | 759 | 0.050 |
Why?
| | RNA, Viral | 1 | 2022 | 123 | 0.050 |
Why?
| | Phase Transition | 1 | 2021 | 6 | 0.040 |
Why?
| | Fluorescence | 1 | 2021 | 30 | 0.040 |
Why?
| | Proto-Oncogene Proteins c-kit | 1 | 2021 | 34 | 0.040 |
Why?
| | Animals | 2 | 2013 | 13526 | 0.040 |
Why?
| | Genome, Mitochondrial | 1 | 2020 | 8 | 0.040 |
Why?
| | Italy | 1 | 2020 | 27 | 0.040 |
Why?
| | Enzyme Activation | 1 | 2021 | 267 | 0.040 |
Why?
| | Bacteroides fragilis | 1 | 2019 | 3 | 0.040 |
Why?
| | Adenosine Diphosphate | 1 | 2019 | 20 | 0.040 |
Why?
| | Fluorescence Resonance Energy Transfer | 1 | 2019 | 17 | 0.040 |
Why?
| | Base Pairing | 1 | 2019 | 27 | 0.040 |
Why?
| | Oxidation-Reduction | 1 | 2021 | 333 | 0.040 |
Why?
| | Stress, Mechanical | 1 | 2019 | 95 | 0.040 |
Why?
| | Proteomics | 1 | 2021 | 336 | 0.040 |
Why?
| | Molecular Structure | 1 | 2018 | 320 | 0.030 |
Why?
| | Chromatography, High Pressure Liquid | 1 | 2019 | 333 | 0.030 |
Why?
| | Tandem Mass Spectrometry | 1 | 2019 | 254 | 0.030 |
Why?
| | Cell Line, Tumor | 1 | 2021 | 1470 | 0.030 |
Why?
| | Nucleic Acid Hybridization | 1 | 2016 | 53 | 0.030 |
Why?
| | DNA, Bacterial | 1 | 2016 | 167 | 0.030 |
Why?
| | Dose-Response Relationship, Drug | 1 | 2018 | 1367 | 0.030 |
Why?
| | Magnesium | 1 | 2014 | 33 | 0.030 |
Why?
| | Lysine | 1 | 2014 | 91 | 0.030 |
Why?
| | N-Acetylneuraminic Acid | 1 | 2013 | 13 | 0.030 |
Why?
| | Chemical Fractionation | 1 | 2013 | 17 | 0.030 |
Why?
| | Mixed Function Oxygenases | 1 | 2013 | 25 | 0.030 |
Why?
| | Protein Processing, Post-Translational | 1 | 2014 | 149 | 0.020 |
Why?
| | Conserved Sequence | 1 | 2013 | 55 | 0.020 |
Why?
| | Static Electricity | 1 | 2012 | 22 | 0.020 |
Why?
| | Chromatography, Liquid | 1 | 2013 | 245 | 0.020 |
Why?
| | Protein Structure, Secondary | 1 | 2012 | 71 | 0.020 |
Why?
| | Sequence Alignment | 1 | 2012 | 119 | 0.020 |
Why?
| | Flow Cytometry | 1 | 2013 | 400 | 0.020 |
Why?
| | Plasmids | 1 | 2012 | 164 | 0.020 |
Why?
| | Blood Platelets | 1 | 2013 | 247 | 0.020 |
Why?
| | Cloning, Molecular | 1 | 2011 | 175 | 0.020 |
Why?
| | Fluorescein | 1 | 2010 | 8 | 0.020 |
Why?
| | Least-Squares Analysis | 1 | 2010 | 44 | 0.020 |
Why?
| | Spectrometry, Fluorescence | 1 | 2010 | 45 | 0.020 |
Why?
| | Staining and Labeling | 1 | 2010 | 94 | 0.020 |
Why?
| | Mice, Inbred C57BL | 1 | 2013 | 1925 | 0.020 |
Why?
| | Mice | 1 | 2013 | 5982 | 0.010 |
Why?
| | Oligodeoxyribonucleotides | 1 | 2002 | 27 | 0.010 |
Why?
| | Biotin | 1 | 2002 | 46 | 0.010 |
Why?
| | Male | 1 | 2013 | 27435 | 0.010 |
Why?
|
|
Byrd's Networks
Click the "See All" links for more information and interactive visualizations!
Concepts  Derived automatically based on a person's publications. Keywords from attributed publications are matched to keywords from the MeSH. _
Co-Authors People in Profiles who have published with this person. _
Similar People People who share similar concepts with this person. _
Same Department
People who are also in this person's primary department.
|